{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:43:46Z","timestamp":1790401426624,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"French Ministry of Health","award":["PHRC-2013-0919"],"award-info":[{"award-number":["PHRC-2013-0919"]}]},{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation pour la recherche sur Alzheimer"},{"name":"Institut de recherche Servier"},{"DOI":"10.13039\/501100003750","name":"Association France Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00415-019-09530-7","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T16:06:02Z","timestamp":1568822762000},"page":"3087-3097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["[18F]-AV-1451 tau PET imaging in Alzheimer\u2019s disease and suspected non-AD tauopathies using a late acquisition time window"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-261X","authenticated-orcid":false,"given":"Julien","family":"Lagarde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Caill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"9530_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","volume":"14","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL et al (2015) Tau imaging: early progress and future directions. Lancet Neurol 14:114\u2013124","journal-title":"Lancet Neurol"},{"key":"9530_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34:457\u2013468","journal-title":"J Alzheimers Dis"},{"key":"9530_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marqui\u00e9","year":"2015","unstructured":"Marqui\u00e9 M, Normandin MD, Vanderburg CR et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787\u2013800","journal-title":"Ann Neurol"},{"key":"9530_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR et al (2016) PET imaging of tau deposition in the aging human brain. Neuron 89:971\u2013982","journal-title":"Neuron"},{"key":"9530_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB et al (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539\u20131550","journal-title":"Brain"},{"key":"9530_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00401-017-1740-8","volume":"134","author":"M Marqui\u00e9","year":"2017","unstructured":"Marqui\u00e9 M, Siao Tick Chong M, Ant\u00f3n-Fern\u00e1ndez A et al (2017) [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging. Acta Neuropathol 134:619\u2013628","journal-title":"Acta Neuropathol"},{"key":"9530_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58","journal-title":"Acta Neuropathol Commun"},{"key":"9530_CR8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.0000000000004364","volume":"89","author":"H Cho","year":"2017","unstructured":"Cho H, Baek MS, Choi JY et al (2017) 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome. Neurology 89:1170\u20131178","journal-title":"Neurology"},{"key":"9530_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cortex.2017.12.021","volume":"99","author":"RL Utianski","year":"2018","unstructured":"Utianski RL, Whitwell JL, Schwarz CG et al (2018) Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech. Cortex 99:358\u2013374","journal-title":"Cortex"},{"key":"9530_CR10","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Sch\u00f6ll M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372\u20132379","journal-title":"Brain"},{"key":"9530_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.0000000000003636","volume":"88","author":"S Spina","year":"2017","unstructured":"Spina S, Schonhaut DR, Boeve BF et al (2017) Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology 88:758\u2013766","journal-title":"Neurology"},{"key":"9530_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2018.02.015","volume":"66","author":"H Cho","year":"2018","unstructured":"Cho H, Seo SW, Choi JY et al (2018) Predominant subcortical accumulation of 18F-flortaucipir binding in behavioral variant frontotemporal dementia. Neurobiol Aging 66:112\u2013121","journal-title":"Neurobiol Aging"},{"key":"9530_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00259-018-4125-x","volume":"46","author":"HJ Son","year":"2019","unstructured":"Son HJ, Oh JS, Roh JH et al (2019) Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias. Eur J Nucl Med Mol Imaging 46:357\u2013366","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9530_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","volume":"11","author":"RM Tsai","year":"2019","unstructured":"Tsai RM, Bejanin A, Lesman-Segev O et al (2019) 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res Ther 11:13","journal-title":"Alzheimers Res Ther"},{"key":"9530_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2967\/jnumed.116.182881","volume":"58","author":"O Barret","year":"2017","unstructured":"Barret O, Alagille D, Sanabria S et al (2017) Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects. J Nucl Med 58:1124\u20131131","journal-title":"J Nucl Med"},{"key":"9530_CR16","unstructured":"Wimberley C, Lagarde J, Olivieri P et al (2018) Optimal time window for [18F]-AV-1451 binding quantification in AD using SUVr [abstract]. In: 12th Human Amyloid Imaging, Miami January 17\u201319 2018, p101."},{"key":"9530_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.24885","volume":"81","author":"EG Spinelli","year":"2017","unstructured":"Spinelli EG, Mandelli ML, Miller ZA et al (2017) Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 81:430\u2013443","journal-title":"Ann Neurol"},{"key":"9530_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G et al (2016) Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain 139:1252\u20131264","journal-title":"Brain"},{"key":"9530_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477","journal-title":"Brain"},{"key":"9530_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006\u20131014","journal-title":"Neurology"},{"key":"9530_CR21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2967\/jnumed.107.045351","volume":"49","author":"FC Sureau","year":"2008","unstructured":"Sureau FC, Reader AJ, Comtat C et al (2008) Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J Nucl Med 49:1000\u20131008","journal-title":"J Nucl Med"},{"key":"9530_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00259-009-1156-3","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Sj\u00f6holm N, Eriksson L et al (2009) Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging 36:1639\u20131650","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"9530_CR23","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/j.neuroimage.2004.07.019","volume":"23","author":"JF Mangin","year":"2004","unstructured":"Mangin JF, Rivi\u00e8re D, Cachia A et al (2004) A framework to study the cortical folding patterns. Neuroimage 23(Suppl 1):S129\u2013S138","journal-title":"Neuroimage"},{"key":"9530_CR24","first-page":"309","volume":"135","author":"CL Joachim","year":"1989","unstructured":"Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer\u2019s disease. Am J Pathol 135:309\u2013319","journal-title":"Am J Pathol"},{"key":"9530_CR25","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/brain\/awr130","volume":"134","author":"LC de Souza","year":"2011","unstructured":"de Souza LC, Corlier F, Habert M-O et al (2011) Similar amyloid-\u03b2 burden in posterior cortical atrophy and Alzheimer\u2019s disease. Brain 134:2036\u20132043","journal-title":"Brain"},{"key":"9530_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT et al (2016) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79:272\u2013287","journal-title":"Ann Neurol"},{"key":"9530_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0002-9440(10)61154-6","volume":"160","author":"MS Forman","year":"2002","unstructured":"Forman MS, Zhukareva V, Bergeron C et al (2002) Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 160:2045\u20132053","journal-title":"Am J Pathol"},{"key":"9530_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fninf.2016.00030","volume":"10","author":"JV Manj\u00f3n","year":"2016","unstructured":"Manj\u00f3n JV, Coup\u00e9 P (2016) volBrain: an online MRI brain volumetry system. Front Neuroinform 10:30","journal-title":"Front Neuroinform"},{"key":"9530_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","volume":"5","author":"M Marqui\u00e9","year":"2017","unstructured":"Marqui\u00e9 M, Verwer EE, Meltzer AC et al (2017) Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case. Acta Neuropathol Commun 5:75","journal-title":"Acta Neuropathol Commun"},{"key":"9530_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.117.195248","volume":"59","author":"JY Choi","year":"2018","unstructured":"Choi JY, Cho H, Ahn SJ et al (2018) Off-target 18F-AV-1451 binding in the basal ganglia correlates with age-related iron accumulation. J Nucl Med 59:117\u2013120","journal-title":"J Nucl Med"},{"key":"9530_CR31","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1021\/acschemneuro.9b00326","volume":"10","author":"LR Drake","year":"2019","unstructured":"Drake LR, Pham JM, Desmond TJ et al (2019) Identification of AV-1451 as a weak, nonselective inhibitor of monoamine oxidase. ACS Chem Neurosci 10:3839\u20133846","journal-title":"ACS Chem Neurosci"},{"key":"9530_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11307-017-1143-1","volume":"20","author":"AK Hansen","year":"2018","unstructured":"Hansen AK, Brooks DJ, Borghammer P (2018) MAO-B inhibitors do not block in vivo flortaucipir ([18F]-AV-1451) binding. Mol Imaging Biol 20:356\u2013360","journal-title":"Mol Imaging Biol"},{"key":"9530_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2967\/jnumed.116.175273","volume":"58","author":"SL Baker","year":"2017","unstructured":"Baker SL, Lockhart SN, Price JC et al (2017) Reference tissue-based kinetic evaluation of 18F-AV-1451 for tau imaging. J Nucl Med 58:332\u2013338","journal-title":"J Nucl Med"},{"key":"9530_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2967\/jnumed.115.170910","volume":"58","author":"DW Wooten","year":"2017","unstructured":"Wooten DW, Guehl NJ, Verwer EE et al (2017) Pharmacokinetic evaluation of the tau PET radiotracer 18F\u2013T807 (18F-AV-1451) in human subjects. J Nucl Med 58:484\u2013491","journal-title":"J Nucl Med"},{"key":"9530_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.25060","volume":"82","author":"DR Schonhaut","year":"2017","unstructured":"Schonhaut DR, McMillan CT, Spina S et al (2017) 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol 82:622\u2013634","journal-title":"Ann Neurol"},{"key":"9530_CR36","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1212\/01.wnl.0000436070.28137.7b","volume":"81","author":"JM Harris","year":"2013","unstructured":"Harris JM, Gall C, Thompson JC et al (2013) Classification and pathology of primary progressive aphasia. Neurology 81:1832\u20131839","journal-title":"Neurology"},{"key":"9530_CR37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/jnnp-2017-316402","volume":"89","author":"WR Bevan-Jones","year":"2018","unstructured":"Bevan-Jones WR, Cope TE, Jones PS et al (2018) [18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1032\u20131037","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9530_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/jnnp-2017-316409","volume":"89","author":"SJ Makaretz","year":"2018","unstructured":"Makaretz SJ, Quimby M, Collins J et al (2018) Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1024\u20131031","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9530_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/jnnp-2015-310697","volume":"87","author":"SC Lanata","year":"2016","unstructured":"Lanata SC, Miller BL (2016) The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry. J Neurol Neurosurg Psychiatry 87:501\u2013511","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09530-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T01:36:31Z","timestamp":1600306591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9530"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09530-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}